Abstract
Abstract
Background
Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycaemia and dyslipidaemia, leading to severe microvascular and macrovascular complications. Although vildagliptin is an effective dipeptidyl peptidase-4 (DPP-4) inhibitor, combination strategies involving medicinal plants may enhance therapeutic efficacy through complementary mechanisms.
Ziziphus nummularia
has long been used in traditional medicine for diabetes management; however, its potential as an adjunct to DPP-4 inhibitor therapy has not been comprehensively investigated.
Objective
To evaluate the antihyperglycaemic and antidyslipidaemic effects of hydroalcoholic leaf and fruit extracts of
Ziziphus nummularia
, administered alone and in combination with vildagliptin, in alloxan-induced diabetic rats.
Methods
Experimental diabetes was induced in male Wistar albino rats using alloxan monohydrate (150 mg/kg, i.p.). Hydroalcoholic leaf (ZNLE) and fruit (ZNFE) extracts were administered orally at doses of 125, 250, and 500 mg/kg for 28 days. Vildagliptin (0.3 mg/kg) served as the reference drug. Fasting blood glucose and serum lipid profile were analysed using standard biochemical methods. In addition, the antioxidant potential of Ziziphus nummularia extracts was evaluated using in vitro DPPH and superoxide radical scavenging assays, while in vivo antioxidant activity was assessed by measuring superoxide dismutase (SOD) and malondialdehyde (MDA) levels. The extracts were phytochemically characterized using qualitative screening, TLC, HPLC, GC–MS, FTIR, NMR, and quantitative estimation of total phenolic and total flavonoid contents.
Results
Both extracts significantly reduced fasting blood glucose and improved serum lipid parameters in a dose-dependent manner (
p
Conclusion
Hydroalcoholic extracts of Ziziphus nummularia exhibited antihyperglycaemic and antidyslipidaemic activities in alloxan-induced diabetic rats. Combination treatment with vildagliptin produced greater improvements in glycaemic and lipid parameters than the corresponding monotherapies; however, formal pharmacological synergy was not evaluated. The findings provide preliminary preclinical evidence supporting further investigation of Z. nummularia extracts, including their combination with conventional antidiabetic treatment, with particular emphasis on mechanistic validation and comprehensive safety assessment.
Clinical trial number
Not applicable.
The overall study workflow and experimental design are illustrated in Graphical Abstract figure.